TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

I PEACE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

I PEACE

ST13

US500000079339458

Classe

1, 3, 5, 39, 42, 44

Pedido

79339458

Registro

7135012

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

28/02/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 3, 5, 39, 42, 44

Data de depósito

15/09/2021

Data de registro

15/08/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/08/2023

Última transação

15/08/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

US

Examinador

CANTONE, KERI

Unidade examinadora

L40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

I Peace, Inc.

Representantes

M. Scott Alprin Alprin Law Offices, P.C.

Classificação técnica

Classes Nice

Classe 1Classe 3Classe 5Classe 39Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Cell culture media for laboratory use, other than for medical or veterinary purposes; microorganism culture media for laboratory use, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for manufacture of cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes

Classe 3

Cosmetics containing culture fluid for human stem cell; cosmetics; bath and cosmetic soaps and laundry and dishwasher detergents; dentifrices; perfumery

Classe 5

Stem cells for medical purposes; stem cells for clinical medical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use derived from iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; pharmaceutical preparations for human use developed by using iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; dietary supplements; dietetic preparations adapted for medical purposes

Classe 39

Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services

Classe 42

Cell culture services for scientific and research purposes for others; providing scientific information related to cell culture; cytogenetic examination being cytogenic research services for others; testing examination, research and development in the field of regenerative medicine; testing, examination, research and development in the field of cytology; testing, examination, research and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals

Classe 44

Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment of speech disorders, breast cancer and infertility, neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease, not limited to stem cells; preservation of human blood as a supply source of stem cells; clinical medical examination; evaluation of clinical examination for medical purposes; genetic testing for medical purposes; providing medical facilities; Health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

28/02/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

01/01/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/12/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

16/11/2023

FIMP

FINAL DISPOSITION PROCESSED

15/11/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

15/11/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

15/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

15/08/2023

GPNX

NOTIFICATION PROCESSED BY IB

30/05/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/05/2023

PUBO

PUBLISHED FOR OPPOSITION

30/05/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/05/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

25/04/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

25/04/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

25/04/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

25/04/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

25/04/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/01/2023

GNFR

FINAL REFUSAL E-MAILED

09/01/2023

CNFR

FINAL REFUSAL WRITTEN

09/01/2023

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

27/12/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

27/12/2022

RFNT

REFUSAL PROCESSED BY IB

17/08/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/07/2022

RFRR

REFUSAL PROCESSED BY MPU

26/07/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/06/2022

CNRT

NON-FINAL ACTION WRITTEN

27/06/2022

DOCK

ASSIGNED TO EXAMINER

19/06/2022

MAFR

APPLICATION FILING RECEIPT MAILED

17/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/05/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/05/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/04/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace I PEACE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.